Single Brain Metastasis
Showing 1 - 25 of >10,000
Brain Metastases, Adult, Non Small Cell Lung Cancer, Breast Cancer Trial in Messina, Rome, Turin (Silibinin, Placebo)
Recruiting
- Brain Metastases, Adult
- +2 more
- Silibinin
- Placebo
-
Messina, Italy
- +4 more
Jan 9, 2023
NSCLC, Renal Cell Carcinoma, Breast Carcinoma Trial (single fraction stereotactic radiosurgery (SSRS), fractionated stereotactic
Not yet recruiting
- NSCLC
- +5 more
- single fraction stereotactic radiosurgery (SSRS)
- fractionated stereotactic radiosurgery (FSRS)
- (no location specified)
Jan 18, 2023
Brain Metastases Trial in Seoul (BT-M01)
Recruiting
- Brain Metastases
- BT-M01
-
Seoul, Song-pa Gu, Korea, Republic ofAsan Medical Center
Oct 6, 2022
Breast Cancer With Brain Metastases Trial in Wuhan (pyrotinib+capecitabine+bevacizumab)
Recruiting
- Breast Cancer With Brain Metastases
-
Wuhan, Hubei, ChinaTongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 22, 2023
NSCLC Stage II, Bevacizumab, Immunotherapy Trial in Guangzhou (Serplulimab combined with bevacizumab and first-line chemo)
Not yet recruiting
- Non-small Cell Lung Cancer Stage II
- +3 more
- Serplulimab combined with bevacizumab and first-line chemotherapy
-
Guangzhou, Guangdong, ChinaLikun Chen
Apr 10, 2023
Brain Metastases, Adult Trial in Durham (Stereotactic radiosurgery)
Completed
- Brain Metastases, Adult
- Stereotactic radiosurgery
-
Durham, North CarolinaDuke University Medical Center
May 9, 2022
Breast Cancer Trial in Zhengzhou (utidelone, Bevacizumab)
Recruiting
- Breast Cancer
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Sep 15, 2022
Metastatic HER2 Negative Breast Carcinoma, Brain Metastases, Capecitabine Trial in Changsha (UTD1 combined with capecitabine)
Recruiting
- Metastatic HER2 Negative Breast Carcinoma
- +3 more
- UTD1 combined with capecitabine
-
Changsha, ChinaQuchang Ouyang
Sep 9, 2022
Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)
Not yet recruiting
- Metastatic Breast Cancer
- +2 more
- Patritumab deruxtecan
- (no location specified)
May 9, 2023
Brain Metastases Trial in Changsha (ASCLU-300 TTF)
Recruiting
- Brain Metastases
- ASCLU-300 TTF
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Feb 27, 2022
Tumor Metastasis, CNS Metastases Trial in Albuquerque (Intensity Modulated Radiotherapy)
Completed
- Neoplasm Metastasis
- Central Nervous System Metastases
- Intensity Modulated Radiotherapy
-
Albuquerque, New MexicoUniverstiy of New Mexico Comprehensive Cancer Center
Apr 21, 2022
Malignant Tumors, Brain Lymphoma, CNS Lymphoma Trial in Seoul (Usefulness of Gadovist-enhanced FLAIR imaging in differentiation
Completed
- Malignant Tumors
- +2 more
- Usefulness of Gadovist-enhanced FLAIR imaging in differentiation between a glioblastoma and solitary brain metastasis
-
Seoul, Gurogu, Korea, Republic ofKorea University Guro Hospital
Mar 14, 2022
Lung Cancer, Lung Cancer Metastatic, Brain Metastases Trial in United States (Stereotactic Radiosurgery, Cerebrospinal fluid
Recruiting
- Lung Cancer
- +5 more
- Stereotactic Radiosurgery
- Cerebrospinal fluid collection
-
Basking Ridge, New Jersey
- +6 more
Nov 11, 2022
Malignant Tumors of Eye Brain and Other Parts of CNS Trial in Houston (Spine Radiosurgery, Questionnaires)
Recruiting
- Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System
- Spine Radiosurgery
- Questionnaires
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 22, 2022
Brain Metastases, Posterior Fossa Lesion, Cerebral Lesion Trial in Jerusalem (Radiation treatment)
Recruiting
- Brain Metastases
- +2 more
- Radiation treatment
-
Jerusalem, IsraelHadassah Ein Kerem Medical Center
Jul 25, 2022
Breast Cancer, Brain Metastases, HER2-positive Breast Cancer Trial in Los Angeles (Tucatinib, Pembrolizumab, Trastuzumab)
Withdrawn
- Breast Cancer
- +3 more
- Tucatinib
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jun 28, 2022
Brain Metastasis, Oligoprogression Trial in France (Hypofractionated SRT (stereotactic radiotherapy), Historical single-dose SRS
Active, not recruiting
- Brain Metastasis
- Oligoprogression
- Hypofractionated SRT (stereotactic radiotherapy)
- Historical single-dose SRS (stereotactic radiosurgery)
-
Bordeaux, France
- +12 more
Aug 9, 2022
Cerebral Metastases of Solid Cancers Trial in Erlangen (Radiosurgery, Fractionated stereotactic radiotherapy)
Recruiting
- Cerebral Metastases of Solid Cancers
- Radiosurgery
- Fractionated stereotactic radiotherapy
-
Stuttgart, Baden-Württemberg, Germany
- +12 more
Dec 9, 2022
Brain Metastases, Resection Cavity Trial in Munich (Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction
Recruiting
- Brain Metastases
- Resection Cavity
- Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiotherapy radiosurgery (SRS)
-
Munich, Bavaria, GermanyDept. Radiation Oncology
Dec 6, 2021
Brain Metastases, Breast Cancer, Metastatic Breast Cancer Trial in Multiple Locations (BKM120, capecitabine, Trastuzumab)
Completed
- Brain Metastases
- +2 more
- BKM120
- +2 more
-
Multiple Locations, TexasPlease contact Zuzanne Bristow for list of sites
Jan 31, 2022
Brain Metastases, Adult, Cancer Brain Trial in Switzerland (IGRT, SRS)
Recruiting
- Brain Metastases, Adult
- Cancer Brain
- IGRT
- SRS
-
Bellinzona, Ticino, Switzerland
- +5 more
Feb 9, 2022
Brain Metastases, Brain Metastases, Adult, Brain Cancer Trial in Miami (18F fluciclovine)
Not yet recruiting
- Brain Metastases
- +2 more
- 18F fluciclovine
-
Miami, FloridaMiami Cancer Institute
Sep 15, 2023
NSCLC Stage IV, Brain Metastases, Immunotherapy Trial in Hangzhou (Immunotherapy, WBRT, Chemotherapy)
Recruiting
- NSCLC Stage IV
- +2 more
- Immunotherapy
- +2 more
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Sep 3, 2021